Affiliations 

  • 1 Department of Hematology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kelantan, Malaysia
  • 2 Department of Pathology (Hematology), Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia
  • 3 Hematology Unit, Institute for Medical Research, Kuala Lumpur, Malaysia
Oman Med J, 2022 Jan;37(1):e331.
PMID: 35136660 DOI: 10.5001/omj.2021.48

Abstract

Patients with heterozygous β-thalassemia are generally asymptomatic. However, the intermediate phenotype is uncommon, and patients require further investigation to confirm the diagnosis. We describe a 32-year-old woman (gravida 3, para 2) with heterozygous β-thalassemia who presented with symptomatic anemia and had a history of frequent blood transfusion in each pregnancy. Physical examination was unremarkable. Laboratory results at presentation showed hypochromic microcytic anemia with reticulocytosis. Molecular study revealed intermedia phenotypes resulting from coinheritance of heterozygous β-globin chain mutation (IVS1-5) and a rare heterozygous α-globin triplication (αααanti-3.7). In this case report, we discuss the laboratory diagnostic approaches and the challenges faced in investigating this case.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.